BT-GSI
BT-GSI is a γ-secretase inhibitor (GSI) and a bone-targeted Notch inhibitor. BT-GSI has dual anti-myeloma and anti-resorptive properties, which can be used for the research of multiple myeloma and associated bone disease. BT-GSI inhibits tumor growth and osteolytic disease progression.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C26H46BrN5O10P2
- Masse moléculaire:730.52
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Chemical Information
-
Masse moléculaire 730.52
-
Formule C26H46BrN5O10P2
-
SMILES
O=P(O)(O)C(P(O)(O)=O)NC(CCCN(C)/N=C/[C@H](CC(C)C)NC([C@H]([C@@H](C)CC)NC(OCC1=CC=CC=C1)=O)=O)=O.Br
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)